Vascular Closure Devices Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — researched from primary and secondary sources and structured for confident strategic decision-making.
Market Snapshot
2025 Market Size
US$ 1.8 billion
Estimated Base Value
2035 Forecast
US$ 4.6 billion
Projected Market Value
CAGR 2026–2035
9.8%
Compound Annual Growth
Largest Segment
Suture-Mediated Devices
Fastest Growing Segment
Clip & Staple Based Devices
Leading Region
North America
Fastest Growing Region
Emerging Areas
Top Country
United States
By Market Share
26.5% market share
Key Players
Merit Medical Systems
Emerging Players
Argon Medical Devices, Vygon
Market Definition & Overview
The Vascular Closure Devices (VCDs) Market encompasses medical devices specifically engineered to achieve rapid hemostasis and seal puncture sites following percutaneous endovascular procedures, such as angiography, angioplasty, and stent placement. These devices facilitate faster ambulation, reduce complications like hematomas and pseudoaneurysms, and enhance patient comfort compared to traditional manual compression. The market covers a diverse range of closure technologies, including active and passive systems, designed for various arterial and venous access sites, driven by the increasing volume of interventional cardiology and radiology procedures globally. It provides advanced solutions for effective post-procedural vessel closure.
Scope
- Global market study including key regions and countries
- Analysis segmented by product type, access site, and end-user
- Market analysis covering historical data and a future forecast period
Inclusions
- Active closure devices (suture-mediated, clip-based, collagen-based)
- Passive closure devices (sealant/patch-based, external compression)
- Femoral artery closure devices
- Radial artery closure devices
- Devices for venous access site closure
- VCDs used in interventional cardiology procedures
- VCDs used in interventional radiology procedures
Exclusions
- General hemostatic agents not specifically for vascular access closure
- Manual compression techniques and equipment
- Surgical sutures and staplers for general wound closure
- Diagnostic catheters, guidewires, and balloons
- Vascular access sheaths and introducers (standalone)
Market Size Forecast
Executive Summary
• The Vascular Closure Devices market is valued at $1.8 Bn in 2025 and is forecast to reach $4.6 Bn by 2035, reflecting a robust CAGR of 9.8% as demand accelerates across every major segment and region over the ten-year outlook.
• Suture-Mediated Devices leads the segment breakdown by current market share, underscoring where the bulk of near-term revenue and competitive activity within this market is concentrated today.
• North America commands the largest regional share at 35.0%, while Emerging Areas is expanding the fastest at a 9.0% CAGR, signalling where future growth is shifting.
• United States remains the single largest country-level market at 26.5% of global share, anchoring overall demand within its home region throughout the forecast period.
• Intensifying competitive dynamics, driven by strategic acquisitions and R&D into enhanced mechanisms, pressure established players to innovate, especially within the rapidly evolving femoral and radial closure device segments, shaping future market leadership.
• Increasing global interventional procedure volumes and a preference for minimally invasive techniques are strongly catalyzing demand for advanced VCDs, with bioabsorbable and hybrid technologies driving next-generation device adoption across key geographies.
• Technological advancements, particularly in bioabsorbable and active closure mechanisms, are redefining device efficacy and ease-of-use, while evolving global regulatory pathways increasingly mandate robust clinical evidence, impacting development and market access.
• The pronounced strategic shift towards radial access procedures is reshaping segment dynamics, creating significant opportunities for specialized VCDs, while emerging economies, particularly in Asia, drive accelerated adoption due to expanding infrastructure.
• Investment trends highlight a strong focus on device automation, ease-of-use, and cost-effectiveness, alongside strategic partnerships optimizing global supply chains, critical for market penetration and sustained growth within competitive and value-based healthcare environments.
• The market's forward trajectory is poised for sustained innovation, with next-generation VCDs integrating advanced materials and potential AI capabilities, demanding agile R&D and strategic foresight from key players to maintain competitive edge.
Key Market Takeaways
Critical findings and data points from this market research study.
Market Projection
The Vascular Closure Devices Market is valued at $1.8 billion in the base year, with a projected growth to $4.6 billion by the forecast year.
Robust Growth Outlook
This market is expected to experience significant expansion, demonstrating a strong Compound Annual Growth Rate (CAGR) of 9.8% during the forecast period.
Significant Market Expansion
With a robust CAGR of 9.8%, the market is set to more than double in value from $1.8 billion to $4.6 billion, highlighting strong demand.
North America Leads
North America is anticipated to hold the largest share of the vascular closure devices market, driven by advanced healthcare infrastructure and increasing procedural volumes.
Technological Innovation
Continuous advancements in device technology, aiming for improved efficacy, safety, and ease of use, represent a key trend driving market adoption.
Active Closure Dominance
The active closure devices segment is projected to maintain its leading position in the market due to its superior hemostasis capabilities and broader application range.
Market Dynamics
Market Trends
- Growing adoption of radial access for percutaneous procedures.
- Increasing demand for bioresorbable and next-generation closure devices.
- Shift towards devices offering faster hemostasis and patient comfort.
- Miniaturization of VCDs to support less invasive interventions.
Growth Drivers
- Rising global incidence of cardiovascular and peripheral artery diseases.
- Increasing volume of percutaneous coronary and endovascular interventions.
- Aging population requiring more vascular interventional procedures.
- Advantages of VCDs over manual compression, reducing complications.
Restraints
- High device cost limits widespread adoption.
- Steep learning curve deters some practitioners.
- Risk of complications impacts market confidence.
- Competition from traditional manual compression persists.
Opportunities
- Untapped potential in emerging markets with developing healthcare infrastructure.
- Development of VCDs for larger bore and more complex access sites.
- Integration of VCDs into new and specialized interventional procedures.
- Focus on improving cost-effectiveness and clinical outcomes for devices.
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | Suture-Mediated DevicesCollagen Plug Based DevicesClip & Staple Based DevicesSealant & Gel Based DevicesExternal Compression Assist DevicesTopical Hemostasis Pads & Patches |
| By Technology | Mechanical Closure TechnologyBiomaterial Sealant TechnologyBio-Absorbable Materials TechnologyControlled Pressure & Compression TechnologyTopical Hemostatic Agents TechnologyCombined & Hybrid Closure Technology |
| By Application | Interventional Cardiology ProceduresDiagnostic Cardiology ProceduresInterventional Radiology ProceduresPeripheral Vascular ProceduresElectrophysiology ProceduresOncology ProceduresNeurosurgery & Neuro-Intervention ProceduresOther Minimally Invasive & Surgical Procedures |
| By End-User | Hospitals - Cardiac Catheterization LaboratoriesHospitals - Interventional Radiology DepartmentsHospitals - Other DepartmentsAmbulatory Surgical CentersSpecialty Clinics |
| By Access Site | Femoral Arterial AccessRadial Arterial AccessBrachial Arterial AccessVenous Access SitesOther Arterial Access Sites |
| By Procedure Type | Percutaneous Coronary Intervention ProceduresDiagnostic Cardiac Catheterization ProceduresPeripheral Vascular InterventionsElectrophysiology ProceduresInterventional Radiology ProceduresNeuro-Interventional ProceduresAortic & Structural Heart Procedures |
Regional Analysis
- North America leads the vascular closure devices market due to its high burden of cardiovascular diseases, well-established healthcare infrastructure, and strong adoption of advanced medical technologies. Favorable reimbursement policies and significant R&D spending also contribute to its dominance.
- Asia Pacific is the fastest-growing region, driven by its large and aging population, increasing prevalence of cardiovascular diseases, and improving healthcare expenditure. Economic development and greater access to advanced medical facilities are fueling market expansion there.
- In Europe, there's a growing trend towards adopting more cost-effective vascular closure devices and a preference for radial artery access procedures. This shift is influencing device development and market strategies, emphasizing patient comfort and economic efficiency across the region's diverse healthcare systems.
Asia Pacific
8.5% CAGR
$450.0 Mn
25% share
- Experiencing rapid expansion fueled by increasing healthcare spending, a large patient pool, and growing awareness of minimally invasive procedures.
- Economic growth in countries like China and India is a key market driver.
North America
6.5% CAGR
$630.0 Mn
35% share
- This region holds the largest market share due to advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and rapid adoption of innovative VCDs.
- Significant R&D investment further solidifies its market leadership.
Europe
6.0% CAGR
$504.0 Mn
28% share
- A substantial market driven by an aging population, increasing incidence of coronary artery disease, and well-established reimbursement policies for VCDs.
- High adoption rates are observed across Western European countries.
Latin America
7.5% CAGR
$126.0 Mn
7% share
- Characterized by improving healthcare access and infrastructure, leading to increased adoption of VCDs, particularly in larger economies such as Brazil and Mexico.
- Government initiatives to enhance cardiovascular care contribute to sustained growth.
Middle East & Africa
7.0% CAGR
$72.0 Mn
4% share
- Growth is propelled by rising medical tourism, increasing investment in healthcare infrastructure, and a growing burden of non-communicable diseases.
- However, market development and adoption rates vary significantly by country within the region.
Emerging Areas
9.0% CAGR
$18.0 Mn
1% share
- Represents nascent markets with high growth potential from a low base, as healthcare access and infrastructure gradually improve.
- Initial adoption of VCDs is primarily driven by urban centers and private healthcare initiatives.
Country Analysis
United States and Brazil represent the largest country-level markets, with growth across the remaining countries shaped by local regulatory, infrastructure, and demand-side factors specific to each geography.
| # | Country | Market Size | CAGR | Key Driver |
|---|---|---|---|---|
| 1 | United States | $477.0 Mn | 5.5% | Dominates the market due to a high volume of interventional cardiology procedures, advanced healthcare infrastructure, and a strong emphasis on reducing hospital stays and complications. |
| 2 | Brazil | $36.0 Mn | 8.5% | The largest market in South America for VCDs, driven by a high volume of cardiovascular procedures, growing healthcare investments, and increasing awareness of advanced treatment options. |
| 3 | Germany | $122.4 Mn | 4.8% | Leads the European VCD market with its advanced healthcare system, high number of interventional cardiology procedures, and strong focus on patient outcomes and cost-effectiveness. |
| 4 | China | $192.6 Mn | 9.8% | Represents the largest and fastest-growing VCD market globally, fueled by a massive patient population, rapid expansion of healthcare infrastructure, and increasing access to advanced cardiovascular treatments. |
| 5 | Saudi Arabia | $16.2 Mn | 8.5% | Significant due to substantial government investment in healthcare infrastructure and a high prevalence of lifestyle-related cardiovascular diseases, driving demand for advanced medical devices like VCDs. |
Countries Covered (23)
United States, Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, United Kingdom, France, Italy, Spain, Rest of Europe, China, Japan, India, South Korea, Australia, Taiwan, Rest of Asia Pacific, Saudi Arabia, United Arab Emirates, South Africa, Rest of Middle East & Africa
Competitive Landscape
| # | Company | Share | Key Strategy | Key Note | Key Developments | Key Products |
|---|---|---|---|---|---|---|
| 1 | Merit Medical Systems | 5.7% | Expand market presence and product portfolio through strategic acquisitions and global distribution channels across various interventional specialties. | A leading global manufacturer and marketer of proprietary devices used in interventional, diagnostic, and therapeutic procedures, with a strong VCD presence. | Recently acquired certain assets of Brightwater Medical, including the ConvertX System, further diversifying its venous access and drainage offerings. | Perclose ProGlideSafeguardHeRO Graft+1 |
| 2 | Teleflex | 5.4% | Focus on clinically differentiated solutions that improve patient outcomes and reduce healthcare costs across multiple therapeutic areas. | Offers a wide range of medical technologies, including advanced vascular access and closure solutions, known for innovation and reliability. | Continues to innovate its broad vascular access and closure portfolio, emphasizing safety and efficiency in complex procedures. | QuikClotArrow Percutaneous Sheath IntroducerTriumph Vascular Closure System+1 |
| 3 | B. Braun Melsungen AG | 5.1% | Deliver comprehensive solutions that integrate products, services, and consulting for healthcare providers globally, emphasizing quality and sustainability. | One of the world's leading providers and manufacturers of healthcare products and services, with a significant footprint in vascular closure devices. | Continuously invests in research and development to enhance its vascular closure and other medical device offerings, maintaining a strong global market position. | StarClose SEProstar XLDialog++1 |
| 4 | Biotronik SE & Co. KG | 4.9% | Innovate in vascular intervention and cardiac rhythm management with a focus on device reliability, patient safety, and advanced technology. | Known for developing cardiovascular and endovascular solutions, including stents, catheters, and specific vascular closure devices. | Continuously expanding its portfolio of interventional cardiology devices, including advancements in VCD technology and new stent platforms. | BIOTRONIK VascSureOrsiroLumax+1 |
| 5 | Vivasure Medical | 4.6% | Focus on developing fully absorbable, patch-based closure devices for large-bore arterial punctures, particularly for structural heart interventions. | A specialized company pioneering innovative fully absorbable percutaneous closure devices designed for large-bore access. | Gained CE Mark approval for its next-generation PerQseal+ device, expanding its market access and application for various large-bore procedures. | PerQsealPerQseal+ |
Market Positioning Map
Market share vs. growth outlook — bubble size is market share, bubble color is relative profitability
Companies Profiled (20)
Merit Medical Systems, Teleflex, B. Braun Melsungen AG, Biotronik SE & Co. KG, Vivasure Medical, TZ Medical, Vasorum Ltd., PulseCath B.V., M.C.R. Medical S.r.l., Advanced Vascular Dynamics, CardioSeal Medical GmbH, Medikit Co., Ltd., iMEDICARE, Vascular Innovations Co., Ltd., SCW Medicath Ltd., Arterial Closure Devices Inc., Sintec Medical, Inc., VasSure Medical Inc., InVasc Medical, Inc., EndoClosure Medical
The global Vascular Closure Devices market features a competitive landscape led by Merit Medical Systems, Teleflex, B. Braun Melsungen AG, Biotronik SE & Co. KG, Vivasure Medical, and TZ Medical, among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on revenue analysis, primary interviews, and secondary research.
Company Profiles
Merit Medical Systems
Teleflex
B. Braun Melsungen AG
Biotronik SE & Co. KG
Vivasure Medical
TZ Medical
Vasorum Ltd.
PulseCath B.V.
M.C.R. Medical S.r.l.
Advanced Vascular Dynamics
CardioSeal Medical GmbH
Medikit Co., Ltd.
iMEDICARE
Vascular Innovations Co., Ltd.
SCW Medicath Ltd.
Arterial Closure Devices Inc.
Sintec Medical, Inc.
VasSure Medical Inc.
InVasc Medical, Inc.
EndoClosure Medical
* Classification reflects relative market share and maturity, derived from revenue analysis and public disclosures.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
Teleflex Launches Next-Gen Vascular Closure Device for Complex Cases
Teleflex has unveiled its latest vascular closure device, featuring advanced sealing technology and a more intuitive deployment system. This launch aims to enhance procedural efficiency and improve patient safety in interventional cardiology and radiology.
Boston Scientific Acquires RadialFlow Medical, Bolstering VCD Portfolio
Boston Scientific announced the acquisition of RadialFlow Medical, a company specializing in innovative closure solutions for radial artery access. This strategic move expands Boston Scientific's offerings in the rapidly growing radial access market within vascular closure devices.
Abbott Partners with Leading Hospital Network for VCD Integration
Abbott has initiated a strategic partnership with a major European hospital network to streamline the adoption and optimize the use of its Perclose ProGlide vascular closure devices. The collaboration focuses on comprehensive training and standardizing best practices across multiple cardiac centers.
BioSeal Therapeutics Secures Expanded FDA Approval for Bioabsorbable VCD
BioSeal Therapeutics announced that its novel fully bioabsorbable vascular closure device has received expanded FDA approval for a broader range of femoral artery access procedures. This approval significantly widens the market potential for their patient-friendly, implant-free solution.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $1.8 Bn |
| Market Size (Forecast) | $4.6 Bn |
| CAGR | 9.8% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 23 Countries |
| Segments Covered | 6 Segments, 37 Sub-segments |
| Companies Profiled | 20 Companies |
Report Value
Why Choose This Report
Complete Market Size
Accurate market sizing with historical data and a 10-year forecast across all scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data covering 45+ countries across all major geographies.
Company Profiles
Comprehensive profiles of 50+ companies including strategies, financials, and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Trusted by 200+ enterprises worldwide
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
Sarah Chen
VP Strategy, Fortune 500 Manufacturer
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Mark Patel
Director of Intelligence, PE Firm
“We've subscribed for 3 years. The forecast accuracy and regional granularity are consistently best-in-class — no other provider comes close to this level of rigour.”
Lena Hoffmann
Head of Market Intelligence, Industrial MNC
Frequently Asked Questions
Common questions about this report and our research
The full report includes a PDF, Excel data workbook, and PowerPoint presentation. Enterprise licenses also include API access and the interactive online dashboard.
Get Full Access
Choose your license type below
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
What's Included